Publications by authors named "Awadhesh K Singh"

Claim this Profile
R
Revisiting Diabetes Classification: Insights Challenges and Clinical Relevance of the ANDIS Framework in the Indian Context.
Akriti Singh, Shambo S Samajdar, Awadhesh K Singh, Mangesh H Tiwaskar, Shashank R Joshi

J Assoc Physicians India· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sitagliptin as an Add-on Therapy to Other Glucose-lowering Agents in Patients with Type 2 Diabetes Mellitus: A Narrative Review.
Sanjay Kalra, Awadhesh Kumar Singh, Sambit Das, Bharadwaja Pendurthi, Shruti Dharmadhikari

J Assoc Physicians India· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Have SGLT-2 inhibitors DELIVERed an EMPhatic win in heart failure and chronic kidney disease?
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh

Expert Opin Pharmacother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy and safety of semaglutide 2.4 mg and tirzepatide 5-15 mg in obesity with or without type 2 diabetes: A systematic review of Phase 3 clinical trials.
Akriti Singh, Awadhesh Kumar Singh, Ritu Singh, Anoop Misra

Diabetes Metab Syndr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial.
Awadhesh Kumar Singh, Ashok Kumar Das, L Sreenivasa Murthy, Samit Ghosal, Rakesh Sahay

Adv Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonarteritic Anterior Ischemic Optic Neuropathy and Semaglutide: What is This All About?
Awadhesh Kumar Singh, Jothydev Kesavadev, Mangesh Tiwaskar

J Assoc Physicians India· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence.
Awadhesh Kumar Singh, Ritu Singh, Akriti Singh, Anoop Misra

Diabetes Metab Syndr· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin Access Enhancement in India: Expert Views on Integrating Interchangeable Biosimilar Insulin Glargine.
K M Prasanna Kumar, Subhankar Chowdhury, Ganapathi Bantwal, A G Unnikrishnan, Sanjay Kalra, Awadhesh Kumar Singh

Cureus· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diet in Thyroid Disorders: A Survey among Clinicians and a Review of the Current Perspective.
Awadhesh Kumar Singh, Subhankar Chatterjee, Akriti Singh, Rana Bhattacharjee

Indian J Endocrinol Metab· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An overview of therapeutic options of obesity management in India: the Integrated Diabetes and Endocrinology Academy (IDEA) 2023 Congress update.
Subir Ray, Nitin Kapoor, Neeta Deshpande, Sanjay Chatterjee, Janardanan Kumar, Awadhesh Kumar Singh

Expert Rev Clin Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and Significance of Dietary Protein in the Management of Type 2 Diabetes and Its Complications in India: An Expert Opinion.
Viswanathan Mohan, Anoop Misra, Anil Bhansali, Awadhesh Kumar Singh, Brij Makkar

J Assoc Physicians India· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and Consensus.
Awadhesh Kumar Singh, Anoop Misra, Ashok Kumar Das, Anish Behl, Ankit Srivastava

J Assoc Physicians India· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor regarding articles on lobeglitazone.
Awadhesh Kumar Singh, Ritu Singh, Kalyan Kumar Gangopadhyay

Diabetes Metab Syndr· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-sugar sweeteners and health outcomes in adults without diabetes: deciphering the WHO recommendations in the Indian context.
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, Shashank R Joshi, Anoop Misra

Diabetes Metab Syndr· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular and Renal Outcomes With Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors Combination Therapy: A Meta-Analysis of Randomized Cardiovascular Outcome Trials.
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh

Endocr Pract· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New-onset diabetes with sodium-glucose cotransporter-2 inhibitors in prediabetes: An updated meta-analysis and possible mechanisms.
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh

Diabetes Metab Syndr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein restriction in adults with chronic kidney disease, with or without diabetes: Integrated Diabetes and Endocrine Academy (IDEA) consensus statement for Indian patients.
Subir Ray, Awadhesh Kumar Singh, Jagat Jyoti Mukherjee, Raja Ramachandran, Upal Sengupta

Diabetes Metab Syndr· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Will lobeglitazone rival pioglitazone? A systematic review and critical appraisal.
Kalyan Kumar Gangopadhyay, Awadhesh Kumar Singh

Diabetes Metab Syndr· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach.
Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S R Aravind, Rajesh Rajput, Awadhesh K Singh

Int J Diabetes Dev Ctries· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis.
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, Anoop Misra, Zachary Bloomgarden

J Diabetes· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials.
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, Anoop Misra

Diabetes Metab Syndr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement.
Arjun Baidya, Asish Kumar Basu, Rana Bhattacharjee, Dibakar Biswas, Kaushik Biswas, Awadhesh Kumar Singh

J Pediatr Endocrinol Metab· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiorenal disease management in type 2 diabetes: An expert consensus.
Viswanathan Mohan, Awadhesh Kumar Singh, Abdul Hamid Zargar, Alan Almeida, Anil Kumar Bhalla

Diabetes Metab Syndr· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone in diabetic kidney disease: A systematic review and critical appraisal.
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, Anoop Misra

Diabetes Metab Syndr· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Risk assessment for periodontal disease associated tooth loss among rural and urban population of 35-44, 45-54, 55-64 and 65-74 years age groups of Barabanki district, Uttar Pradesh, India: An epidemiological study.
Awadhesh Kumar Singh

Natl J Maxillofac Surg· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis